| Micah T Mathai, MD | |
|
13100 E 136th St Ste 2400, Fishers, IN 46037-9810 | |
| (317) 328-6620 | |
| Not Available |
| Full Name | Micah T Mathai |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 13100 E 136th St Ste 2400, Fishers, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407313489 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 01089614A (Indiana) | Primary |
| Entity Name | Indiana University Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
Foundation Medicine, Inc., a personalized cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine clinical care, today announced a strategic collaboration with Celgene Corporation.
People with Alzheimer's disease who used antiepileptic drugs had a higher number of accumulated hospital days than people with Alzheimer's disease who did not use antiepileptics, according to a new study from the University of Eastern Finland.
Thirty-four percent of malaria-endemic countries are complying with WHO guidelines to monitor artemisinin resistance within their borders, the agency said in a report on Thursday, CBS News reports (11/18). Reuters reports that artemisinin "is the best drug available against malaria, especially when used in artemisinin combination therapy (ACT), which combines it with other drugs that finish off the [malaria] parasite" (Nebehay, 11/18).
Defibrotide, a novel drug which modulates the response of blood vessels to injury, was markedly more effective than standard treatment in post-stem cell transplant patients with hepatic veno-occlusive disease, a life threatening toxicity of transplant caused by blockages in tiny blood vessels of the liver, according to a study led by Dana-Farber Cancer Institute scientists.
Data from the RE-NOVATE® II study presented today at the 15th Annual Congress of the European Hematology Association (EHA) have shown that dabigatran etexilate 220mg once daily is as effective and safe as enoxaparin 40mg in preventing venous thromboembolism (VTE) after total hip replacement surgery.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Micah T Mathai, MD 13100 E 136th St Ste 2400, Fishers, IN 46037-9810 Ph: (317) 328-6620 | Micah T Mathai, MD 13100 E 136th St Ste 2400, Fishers, IN 46037-9810 Ph: (317) 328-6620 |
News Archive
Foundation Medicine, Inc., a personalized cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine clinical care, today announced a strategic collaboration with Celgene Corporation.
People with Alzheimer's disease who used antiepileptic drugs had a higher number of accumulated hospital days than people with Alzheimer's disease who did not use antiepileptics, according to a new study from the University of Eastern Finland.
Thirty-four percent of malaria-endemic countries are complying with WHO guidelines to monitor artemisinin resistance within their borders, the agency said in a report on Thursday, CBS News reports (11/18). Reuters reports that artemisinin "is the best drug available against malaria, especially when used in artemisinin combination therapy (ACT), which combines it with other drugs that finish off the [malaria] parasite" (Nebehay, 11/18).
Defibrotide, a novel drug which modulates the response of blood vessels to injury, was markedly more effective than standard treatment in post-stem cell transplant patients with hepatic veno-occlusive disease, a life threatening toxicity of transplant caused by blockages in tiny blood vessels of the liver, according to a study led by Dana-Farber Cancer Institute scientists.
Data from the RE-NOVATE® II study presented today at the 15th Annual Congress of the European Hematology Association (EHA) have shown that dabigatran etexilate 220mg once daily is as effective and safe as enoxaparin 40mg in preventing venous thromboembolism (VTE) after total hip replacement surgery.
› Verified 4 days ago
Dr. Shirley A Thomas, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13914 Southeastern Pkwy, Suite 314, Fishers, IN 46037 Phone: 317-872-1415 Fax: 317-337-2571 | |
Mrs. Caroline Christine Mecker, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 13914 Southeastern Pkwy Ste 110, Fishers, IN 46037 Phone: 317-415-9010 | |
Denise N Rehfuss, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12381 Wheathill Pass, Fishers, IN 46037 Phone: 419-819-6512 | |
Dr. Amy Hoffman Dodson, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13914 Southeastern Pkwy Ste 110, Fishers, IN 46037 Phone: 317-415-9010 | |
David Kiley, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12164 Steepleview Ct, Fishers, IN 46037 Phone: 317-000-0000 | |
Dr. Susan L Benson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13914 Southeastern Pkwy Ste 110, Fishers, IN 46037 Phone: 317-415-9010 |